سعر ليليبل 4 مجم 14 كيس 2024

Montelukast 4 mg oral granules, 14 sachets.

• Prophylaxis and chronic treatment of asthma in children 12 months to 5 years (4 mg oral granules).Population: Children 12 months to 5 yearsDailyMed (U.S. National Library of Medicine)
• Relief of allergic rhinitis symptoms (seasonal from 2 years, perennial from 6 months) when alternative therapies are inadequate or not tolerated.Population: ChildrenDailyMed (U.S. National Library of Medicine)

• Most common (5% or more and above placebo): upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhoea, otitis media, influenza, rhinorrhoea, sinusitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component of the product.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: serious neuropsychiatric events (agitation, aggression, depression, sleep disturbances, suicidal thoughts and behaviour); weigh benefits and risks and reserve for allergic rhinitis with inadequate response to alternatives.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not for acute asthma attacks; do not abruptly substitute for corticosteroids; aspirin-sensitive patients should continue to avoid aspirin/NSAIDs; systemic eosinophilia/Churg-Strauss-type vasculitis reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Cohort studies over decades have not established a drug-associated risk of major birth defects; no adverse developmental effects in animals at high exposures.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Montelukast is present in human milk; available data do not suggest a significant risk to the breastfed infant.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Montelukast: Selective oral antagonist of the cysteinyl leukotriene type-1 (CysLT1) receptor.